This research evaluates the effects of various gene therapy viral vectors on RPE cells to determine efficacy for therapeutic ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector ...

OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical developmentOxford, UK – 20 ...

“The development of this HPLC method highlights Matica Bio’s leadership in viral vector manufacturing and development,” said Paul Kim, CEO of Matica Bio. “We are committed to advancing ...